Day Two: Strategies and Hot Topics in Drug Development |
8–8:05 a.m.
|
Opening Remarks Luisa Salter-Cid, PhD – Flagship Pioneering
|
Fireside Chat - The Future of IO 8:05–8:45 a.m. Moderator: Alexandra Snyder, MD – Generate Biomedicines
|
8:05–8:35 a.m. |
Fireside Chat Priti Hegde, PhD – Kite Pharma Jedd D. Wolchok, MD, PhD – Weill Cornell Medicine
|
Session V: Investor Perspectives 8:35–9:35 a.m. Moderator: Luisa Salter-Cid, PhD – Flagship Pioneering
|
8:35–9 a.m. |
Investor Perspective Jakob Dupont, MD – Safinnova Investments
|
9–9:35 a.m. |
Panel Discussion Christiana Bardon, MD, MBA – MPM BioImpact Jason Ruth, PhD – MRL Ventures Daina Graybosch, PhD – Leerink Jakob Dupont, MD – Safinnova Investments Asish Xavier, PhD, MBA – Venture Investments
|
Break 9:35–9:55 a.m.
|
Session VI: Chimeric Antigen Receptors 9:55–11:35 a.m. Moderator: Pedro Romero, MD – Novigenix
|
9:55–10:20 a.m. |
Where We've Been and Where We're Going Marcela Maus, MD, PhD – Massachusetts General Hospital
|
10:20–10:45 a.m. |
In Vivo Methods of Delivery Chris Ramsborg – Flagship Pioneering
|
10:45–11:10 a.m. |
Acute and Long-Term Safety Denis Migliorini, MD – University of Geneva, Switzerland
|
11:10–11:35 a.m. |
Panel Discussion Marcela Maus, MD, PhD – Massachusetts General Hospital Chris Ramsborg – Flagship Pioneering Denis Migliorini, MD – University of Geneva, Switzerland
|
Lunch 11:35–12:35 p.m.
|
Session VII: Artificial Intelligence 12:35–2:15 p.m. Moderator: Alexandra Synder, MD – Generate Biomedicines
|
12:35–1:05 p.m. |
Target Discovery Philip Tagari (CSO) – insitro
|
1:05–1:25 p.m. |
Creating Drugs (Large Molecules) Heather Van Epps, PhD – Generate Biomedicines
|
1:25–1:45 p.m. |
Creating Drugs (Small Molecules)
|
1:45–2:15 p.m. |
Clinical Trial Execution
|
Break 2:15–2:30 p.m.
|
Session VIII: Immune Cell Engagers 2:30–4:40 p.m. Moderator: Pedro Romero, MD – Novigenix
|
2:30–2:55 p.m. |
T cell Engagers in Solid Tumors Lawrence Fong, MD – UCSF
|
2:55–3:20 p.m. |
Next-Gen Mechanisms of T cell Engagers Danielle Townsley, MD, MSc – Amgen
|
3:20–3:45 p.m. |
T cell Engagers for Liquid Tumors Patrick Baeuerle, PhD – Cullinan Therapeutics |
3:45–4:10 p.m. |
Panel Discussion Moderator: Jessica Kirshner, PhD – Regeneron Pharmaceuticals Inc. Lawrence Fong, MD – UCSF Danielle Townsley, MD, MSc – Amgen Patrick Baeuerle, PhD – Cullinan Therapeutics
|
4:10–4:20 p.m. |
Closing Remarks
|